About Model Medicines

Model Medicines uses human expertise and AI to accelerate the development of life-changing drugs at scale. Model Medicines harnesses AI and ML with its ActivPred AI Drug Discovery Platform to discover drugs that may be repositioned to serve as therapeutics to treat patients suffering from humankind’s toughest diseases. The drugs that Model Medicines discovers can enter clinical trials in as little as several months.

Company Highlights
Year Founded

2019

icon-altEmployees

16

Location (HQ)

USA

Since Last Funding

3 years 7 months

Monthly Website Visitors

5.2K

icon-altTotal Investment Amt

$4.1M

Last Funding Round

Seed

icon-altYoY Headcount Growth

-23.7%

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Similar Companies

Machine Learning

Pharmaceutical

Biotechnology

Biotechnology Research

Medical

Pharmaceuticals

Pharmaceutical Manufacturing